Search Results 551-560 of 2941 for 必应搜索引擎留痕咨询邮箱：lgooxc@hotmail.com

  1. Use of Repetitive Facilitative Exercise Program in Established Stroke - Mayo Clinic

    The purpose of this study is to assess whether a novel therapy approach (repetitive facilitative exercise (RFE)) is more effective than conventional ...

  2. Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma - Mayo Clinic

    To establish whether treatment with Inhaled Lipid Cisplatin (ILC) is effective in delaying/preventing pulmonary relapse in osteosarcoma patients in complete ...

  3. Expanded Access Program (EAP): Allow Patients in the US with Idiopathic Pulmonary Fibrosis Access to Pirfenidone - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. A Study Comparing 1 Subcutaneous Dose Regimen of Fremanezumab Versus Placebo for the Prevention of Persistent Post-Traumatic Headache (PPTH) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  5. Contact - Statistical Genetics and Genetic Epidemiology: Daniel J. Schaid - Mayo Clinic Research

    Contact the Schaid Statistical Genetics and Genetic Epidemiology Lab at Mayo Clinic about methodology and software for genetic studies or about ...

  6. A Study of Pharmacogenomics (PGx) Results and Clinical Data of Chronic Pain Patients to Assess Current and Future Therapeutic Relevance

    The purpose of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of chronic pain patients in order to ...

  7. A Study of Oral LGH447 in Patients with Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    The primary purpose of this dose escalation study is to estimate the maximum tolerated dose (MTD) and/or recommended dose for expansion (RDE) of LGH447 as a ...

  8. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) - Mayo Clinic

    Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) · Overview.

  9. ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 Deficiency - Mayo Clinic

    The purpose of this study (Study INZ701-304 [ADAPT])) is to assess the long-term safety of INZ-701 in patients with ENPP1 Deficiency or ABCC6 Deficiency who ...

  10. A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease - Mayo Clinic

    About this study. The purpose of this study is to assess long-term safety data of GED-0301 for a period of up to 208 weeks in adult subjects (i.e., ...